第六屆疫苗中國發(fā)展國際峰會是2016年中國最大的疫苗行業(yè)國際峰會，幾乎涵蓋了整個疫苗產(chǎn)業(yè)鏈上的所有參與者。在此，我們將邀請超過300位國內(nèi)外人用疫苗及獸用疫苗領(lǐng)域的頂級專家、學(xué)者、企業(yè)高管等行業(yè)領(lǐng)袖共同探討人用及獸用疫苗行業(yè)的最新發(fā)展趨勢，研發(fā)熱點，合作模式，生產(chǎn)技術(shù)、市場及商業(yè)化策略等熱點話題。同時我們將為國內(nèi)外企業(yè)之間、產(chǎn)業(yè)界及學(xué)術(shù)界之間搭建學(xué)習(xí)、合作、交流的平臺，從而推動中國及新興市場疫苗產(chǎn)業(yè)的快速、健康發(fā)展。
主辦單位：上海士研廣告?zhèn)髅接邢薰?/p>
支持單位：
臺灣生物產(chǎn)業(yè)發(fā)展協(xié)會
臺灣生物產(chǎn)業(yè)發(fā)展協(xié)會(Taiwan Bio Industry Organization)成立于1989年，為臺灣歷史最優(yōu)久且涵蓋最多產(chǎn)業(yè)及學(xué)術(shù)代表的生技專業(yè)團(tuán)體，本會會員包含許多根基穩(wěn)固的資深廠商、新興生技公司、學(xué)術(shù)研究機構(gòu)及政府單位代表等，本會以聯(lián)系并結(jié)合產(chǎn)業(yè)界及各學(xué)術(shù)部門，共同推動生物科技產(chǎn)業(yè)，以發(fā)展我國經(jīng)濟及提高全民生活質(zhì)量為宗旨。
本協(xié)會每年除了舉辦各項研討會、訓(xùn)練課程及產(chǎn)業(yè)交流等活動，其中最主要的就是主辦臺灣生技月(BioTaiwan)活動—包含生物科技大展、亞洲生技商機高峰論壇、商機媒合會、兩岸生醫(yī)產(chǎn)業(yè)合作研討會等活動，在產(chǎn)官學(xué)各方的努力經(jīng)營之下，本活動已成為亞太地區(qū)規(guī)模最大、吸引最多國際專業(yè)人士參與的生技活動之一。
中國生物技術(shù)集團(tuán)
中國生物技術(shù)股份有限公司（中生股份）是中國最大的生物制藥企業(yè)。研發(fā)、生產(chǎn)并銷售用于疾病預(yù)防、治療和診斷的一系列生物醫(yī)藥制品。中生股份是中國最大的人用疫苗生產(chǎn)廠家，和中國最大的血液制品生產(chǎn)廠家，供應(yīng)中國國內(nèi)41個疫苗品種中的35種。作為中國生物制藥行業(yè)的領(lǐng)先企業(yè)，中生股份成功研發(fā)上市了一系列行業(yè)領(lǐng)先生物醫(yī)藥產(chǎn)品。
國際疫苗學(xué)會
International Society for Vaccines is an organization that engages, supports and sustains the professional goals of a diverse membership in all areas relevant to vaccines. With the successful conclusion of the 2013 Vaccine and ISV Annual Congress and ISV General Meeting, a new set of elected officials to the Executive Board will guide the Society for the next two years. Goals are focused on expanding the membership database and the enhanced attendance at the Annual Congresses. In addition, an out research initiative has begun to partner with organizations to promote ISV activities, such as VacChina 2014.
國際疫苗研究所
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Its mission is to discover, develop, and deliver safe, effective and affordable vaccines for developing nations. Established in 1997 at the initiative of the United Nations Development Program (UNDP), IVI operates as an independent nonprofit organization under a treaty signed by 35 countries and the World Health Organization (WHO). The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines primarily against enteric and diarrheal infections, Japanese encephalitis, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea, its host country. For more information, please visit www.ivi.int.